Gyre Therapeutics (GYRE) Short-term Investments (2010 - 2026)
Gyre Therapeutics (GYRE) reported Short-term Investments of $12.3 million for Q1 2026, down 16.84% year-over-year from $14.8 million in Q1 2025, and down 20.08% on a QoQ basis from $15.4 million in Q4 2025.
Gyre Therapeutics (GYRE) has 15 years of Short-term Investments data on file, last reported at $12.3 million in Q1 2026.
- Quarterly Short-term Investments fell 16.84% year-over-year to $12.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.3 million (down 16.84% YoY) and the FY2025 annual result came in at $15.4 million, up 3.36% from the prior year.
- Short-term Investments retreated to $12.3 million in Q1 2026 per GYRE's latest filing, from $15.4 million in the prior quarter.
- Across five years, Short-term Investments topped out at $19.6 million in Q3 2025 and bottomed at $7.6 million in Q1 2024.
- The 3-year median for Short-term Investments is $14.8 million (2025), against an average of $13.4 million.
- The widest annual swing landed in 2025, when Short-term Investments jumped 113.55%; it then declined 16.84% in 2026.
- Tracing GYRE's Short-term Investments over 3 years: stood at $14.9 million in 2024, then advanced by 3.36% to $15.4 million in 2025, then declined by 20.08% to $12.3 million in 2026.
- Per Business Quant, the three latest GYRE Short-term Investments figures stand at $12.3 million (Q1 2026), $15.4 million (Q4 2025), and $19.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.31 Mn |
| Dec 31, 2025 | 15.40 Mn |
| Sep 30, 2025 | 19.65 Mn |
| Jun 30, 2025 | 17.87 Mn |
| Mar 31, 2025 | 14.80 Mn |
| Dec 31, 2024 | 14.90 Mn |
| Sep 30, 2024 | 9.20 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Mar 31, 2024 | 7.60 Mn |
| Dec 31, 2021 | 2.50 Mn |
| Sep 30, 2021 | 5.37 Mn |
| Jun 30, 2021 | 12.90 Mn |
| Mar 31, 2021 | 23.96 Mn |
| Dec 31, 2020 | 48.99 Mn |
| Sep 30, 2020 | 77.96 Mn |
| Jun 30, 2020 | 58.09 Mn |
| Mar 31, 2020 | 34.16 Mn |
| Dec 31, 2019 | 61.50 Mn |
| Sep 30, 2019 | 61.93 Mn |
| Jun 30, 2019 | 76.59 Mn |
| Mar 31, 2019 | 50,000.00 |
| Dec 31, 2018 | 50,000.00 |
| Sep 30, 2018 | 50,000.00 |
| Jun 30, 2018 | 175,000.00 |
| Mar 31, 2018 | 175,000.00 |
| Dec 31, 2017 | 5.33 Mn |
| Sep 30, 2017 | 5.73 Mn |
| Jun 30, 2017 | 6.00 Mn |
| Mar 31, 2017 | 12.86 Mn |
| Dec 31, 2016 | 19.47 Mn |
| Sep 30, 2016 | 10.21 Mn |
| Jun 30, 2016 | 12.62 Mn |
| Mar 31, 2016 | 7.09 Mn |
| Dec 31, 2015 | 3.40 Mn |
| Sep 30, 2015 | 13.67 Mn |
| Jun 30, 2015 | 21.58 Mn |
| Mar 31, 2015 | 31.65 Mn |
| Dec 31, 2014 | 278,000.00 |
| Sep 30, 2014 | 52.21 Mn |
| Jun 30, 2014 | 54.30 Mn |
| Mar 31, 2014 | 52.20 Mn |
| Dec 31, 2013 | 37.84 Mn |
| Sep 30, 2013 | 35.02 Mn |
| Jun 30, 2013 | 37.14 Mn |
| Mar 31, 2013 | 39.98 Mn |
| Dec 31, 2012 | 42.72 Mn |
| Sep 30, 2012 | 65.50 Mn |
| Jun 30, 2012 | 84.83 Mn |
| Mar 31, 2012 | 87.89 Mn |
| Dec 31, 2011 | 87.72 Mn |
| Sep 30, 2011 | 82.94 Mn |
| Jun 30, 2011 | 65.04 Mn |
| Dec 31, 2010 | 48.17 Mn |